Yonsei Med J.  2005 Aug;46(4):480-483. 10.3349/ymj.2005.46.4.480.

Correlation of Serotypes and Genotypes of Macrolide-Resistant Streptococcus agalactiae

• Uh Y
• Kim HY
• Jang IH
• Hwang GY
• Yoon KJ

• KMID: 1716516
• DOI: http://doi.org/10.3349/ymj.2005.46.4.480

Abstract

Despite the necessity for studies of group B streptococci (GBS), due to the increase in serious adult infections, the emergence of new serotypes, and the increased resistance to macrolide antibiotics, such studies have been limited in Korea. The primary purpose of the present study was to determine the frequency trends of GBS serotypes, including serotypes VI, VII, and VIII. The final objective was to elucidate the relationship between the genotypes and serotypes of macrolide-resistant GBS isolates from a Korean population. Among 446 isolates of Streptococcus agalactiae, isolated between January 1990 and December 2002 in Korea, the frequency of serotypes were III (36.5%), Ib (22.0%), V (21.1%), Ia (9.6%), VI (4.3%), II (1.8%), VIII (1.3%), IV (1.1%), and VII (0.9%). The resistance rates to erythromycin, by serotype, were 85% (V), 23% (III), 21% (VI), 3% (Ib), and 2% (Ia). Of 135 erythromycin- resistant S. agalactiae, ermB was detected in 105 isolates, mefA in 20 isolates, and ermTR in seven isolates; most type V isolates harbored the ermB gene, Ib type isolates had an equal distribution of resistance genes, type III isolates accounted for 70% of all isolates carrying mefA genes, and one fourth of type VI isolates had mefA genes.

Keyword

Group B streptococci; Streptococcus agalactiae; serotyping; erythromycin; macrolides; antibiotic resistance; genotype

MeSH Terms

Anti-Bacterial Agents/*pharmacology
Drug Resistance, Bacterial
Erythromycin/*pharmacology
Genotype
Serotyping
Streptococcus agalactiae/*classification/*drug effects/genetics

Reference

1. Ko WC, Lee HC, Wang LR, Lee CT, Liu AJ, Wu JJ. Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur J Clin Microbiol Infect Dis. 2001. 20:334–339.

2. Desjardins M, Delgaty KL, Ramotar K, Seetaram C, Toye B. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol. 2004. 42:5620–5623.

3. Betriu C, Culebras E, Gómez M, Rodríguez-Avial I, Sánchez BA, Ágreda MC, et al. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother. 2003. 47:1112–1114.

4. Croak A, Abate G, Goodrum K, Modrzakowski M. Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio. Am J Obstet Gynecol. 2003. 188:1148–1150.

5. Diekema DJ, Andrews JI, Huynh H, Rhomberg PR, Doktor SR, Beyer J, et al. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol. 2003. 41:2659–2661.

6. Lee K, Shin JW, Chong Y, Mikamo H. Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. J Infect Chemother. 2000. 6:93–97.

7. Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Antimicrob Agents Chemother. 2004. 48:2716–2718.

8. Kim HY, Uh Y. Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea. Yonsei Med J. 2004. 45:591–597.

9. Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 1996. 173:365–373.

10. Elliott JA, Farmer KD, Facklam RR. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol. 1998. 36:2115–2116.

11. Von Both U, Ruess M, Mueller U, Fluegge K, Sander A, Berner R. A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J Clin Microbiol. 2003. 41:2166–2169.

12. Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea. J Clin Microbiol. 2004. 42:3306–3308.

13. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis. 2004. 38:1203–1208.

14. Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis. 1999. 179:1030–1033.

15. Matsuura T, Adachi S, Suzuki K, Yamakoshi M, Yamamoto T, Yamamoto T, et al. Clinical isolates of group B streptococci from elderly patients. J Jpn Assoc Infect Dis. 1996. 70:161–167.

16. Okuyama M, Sagayama Y, Nakajima K. An epidemiological study of group A, B, C, and G hemolytic streptococci isolated from elementary school children in the recent 12 years. Part I. Isolation trends. J Jpn Assoc Infect Dis. 1994. 68:656–664.

17. Ekelund K, Slotved HC, Nielsen HU, Kaltoft MS, Konradsen HB. Emergence of invasive serotype VIII group B streptococcal infections in Denmark. J Clin Microbiol. 2003. 41:4442–4444.

18. Fitoussi F, Loukil C, Gros I, Clermont O, Mariani P, Bonacorsi S, et al. Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother. 2001. 45:1889–1891.

19. Tsolia M, Psoma M, Gavrili S, Petrochilou V, Michalas S, Legakis N, et al. Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clin Microbiol Infect. 2003. 9:832–838.

20. Malbruny B, Werno AM, Anderson TP, Murdoch DR, Leclercq R. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. J Antimicrob Chemother. 2004. 54:1040–1044.